In vitro neurotoxicity by ropivacaine is reduced by silencing Cav3.3 T-type calcium subunits in neonatal rat sensory neurons

References

• Qin Q, Yang D, Xie H, et al. Ultrasound guidance improves the success rate of axillary plexus block: a meta-analysis. Brazil J Anesthesiol (Elsevier). 2016;66:115–119.
   PubMedGoogle Scholar
• Moon YE, Choi JH, Park HJ, et al. Ultrasound-guided nerve block with botulinum toxin type A for intractable neuropathic pain. Toxins. 2016;8. [Epub ahead of print]. doi: 10.3390/toxins8010018
   Web of Science ®Google Scholar
• Rochette A, Dadure C, Raux O, et al. Changing trends in paediatric regional anaesthetic practice in recent years. Curr Opin Anaesthesiol. 2009;22:374–377.
   PubMed Web of Science ®Google Scholar
• Munirama S, Joy J, Columb M, et al. A randomised, single-blind technical study comparing the ultrasonic visibility of smooth-surfaced and textured needles in a soft embalmed cadaver model. Anaesthesia. 2015;70:537–542.
   PubMed Web of Science ®Google Scholar
• Moradkhani MR, Karimi A, Negahdari B. Nanotechnology application to local anaesthesia (LA). Artif Cells Nanomed Biotechnol. 2017. [Epub ahead of print]. 10.1080/21691401.2017.1313263
   Web of Science ®Google Scholar
• van Rooyen H. Local anaesthetic agent toxicity. South Afr J Anaesth Anal. 2014;16:83–88.
   Google Scholar
• Farber SJ, Saheb-Al-Zamani M, Zieske L, et al. Peripheral nerve injury after local anesthetic injection. Anesth Analg. 2013;117:731–739.
   PubMed Web of Science ®Google Scholar
• Gold MS, Reichling DB, Hampl KF, et al. Lidocaine toxicity in primary afferent neurons from the rat. J Pharmacol Exp Ther. 1998;285:413–421.
   PubMed Web of Science ®Google Scholar
• Malet A, Faure MO, Deletage N, et al. The comparative cytotoxic effects of different local anesthetics on a human neuroblastoma cell line. Anesth Analg. 2015;120:589–596.
   PubMed Web of Science ®Google Scholar
• Rodola F, Anastasi F, Vergari A. Ropivacaine induced acute neurotoxicity after epidural injection. Eur Rev Med Pharmacol Sci. 2007; 11:133–135.
   PubMed Web of Science ®Google Scholar
• Casati A, Santorsola R, Cerchierini E, Moizo E. Ropivacaine. Minerva Anestesiol. 2001;67(9 Suppl 1):15–19.
   Google Scholar
• Dhir S, Ganapathy S, Lindsay P, et al. Case report: ropivacaine neurotoxicity at clinical doses in interscalene brachial plexus block. Can J Anaesth. 2007; 54:912–916.
   PubMed Web of Science ®Google Scholar
• Williams BA, Hough KA, Tsui BY, et al. Neurotoxicity of adjuvants used in perineural anesthesia and analgesia in comparison with ropivacaine. Reg Anesth Pain Med. 2011;36:225–230.
   PubMed Web of Science ®Google Scholar
• Bourinet E, Francois A, Laffray S. T-type calcium channels in neuropathic pain. Pain. 2016;157 Suppl 1:S15–S22.
   PubMed Web of Science ®Google Scholar
• Cueni L, Canepari M, Adelman JP, et al. Ca(2+) signaling by T-type Ca(2+) channels in neurons. Pflugers Arch. 2009;457:1161–1172.
   PubMed Web of Science ®Google Scholar
• Perez-Reyes E. Molecular characterization of T-type calcium channels. Cell Calcium. 2006; 40:89–96.
   PubMed Web of Science ®Google Scholar
• Ono K, Iijima T. Pathophysiological significance of T-type Ca2+ channels: properties and functional roles of T-type Ca2+ channels in cardiac pacemaking. J Pharmacol Sci. 2005; 99:197–204.
   PubMed Web of Science ®Google Scholar
• Wen XJ, Li ZJ, Chen ZX, et al. Intrathecal administration of Cav3.2 and Cav3.3 antisense oligonucleotide reverses tactile allodynia and thermal hyperalgesia in rats following chronic compression of dorsal root of ganglion. Acta Pharmacol Sin. 2006;27:1547–1552.
   PubMed Web of Science ®Google Scholar
• Wen XJ, Xu SY, Chen ZX, et al. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia. Pharmacology. 2010;85:295–300.
   PubMed Web of Science ®Google Scholar
• Todorovic SM, Jevtovic-Todorovic V. T-type voltage-gated calcium channels as targets for the development of novel pain therapies. Br J Pharmacol. 2011;163:484–495.
   PubMed Web of Science ®Google Scholar
• Wen X, Xu S, Liu H, et al. Neurotoxicity induced by bupivacaine via T-type calcium channels in SH-SY5Y cells. PLoS One. 2013;8:e62942.
   PubMed Web of Science ®Google Scholar
• Wen X, Xu S, Zhang Q, et al. Inhibitory gene expression of the Cav3.1 T-type calcium channel to improve neuronal injury induced by lidocaine hydrochloride. Eur J Pharmacol. 2016;775:43–49.
   PubMed Web of Science ®Google Scholar
• Jevtovic-Todorovic V, Todorovic SM. The role of peripheral T-type calcium channels in pain transmission. Cell Calcium. 2006;40:197–203.
   PubMed Web of Science ®Google Scholar
• Ataei N, Sabzghabaee AM, Movahedian A. Calcium/calmodulin-dependent protein kinase II is a ubiquitous molecule in human long-term memory synaptic plasticity: a systematic review. Int J Prev Med. 2015;6:88.
   PubMed Web of Science ®Google Scholar
• Byth LA. Ca(2+)- and CaMKII-mediated processes in early LTP. Ann Neurosci. 2014;21:151–153.
   PubMedGoogle Scholar
• Erickson JR, Anderson ME. CaMKII and its role in cardiac arrhythmia. J Cardiovasc Electrophysiol. 2008;19:1332–1336.
   PubMed Web of Science ®Google Scholar
• Ghosh A, Giese KP. Calcium/calmodulin-dependent kinase II and Alzheimer’s disease. Mol Brain. 2015;8:78.
   PubMed Web of Science ®Google Scholar
• Shonesy BC, Jalan-Sakrikar N, Cavener VS, et al. CaMKII: a molecular substrate for synaptic plasticity and memory. Prog Mol Biol Transl Sci. 2014;122:61–87.
   PubMed Web of Science ®Google Scholar
• Liu XB, Murray KD. Neuronal excitability and calcium/calmodulin-dependent protein kinase type II: location, location, location. Epilepsia. 2012;53(Suppl 1):45–52.
   PubMed Web of Science ®Google Scholar
• Colbran RJ. Targeting of calcium/calmodulin-dependent protein kinase II. Biochem J. 2004;378:1–16.
   PubMed Web of Science ®Google Scholar
• Wen X, Lai X, Li X, et al. The effects of ropivacaine hydrochloride on the expression of CaMK II mRNA in the dorsal root ganglion neurons. Biomed Pharmacother. 2016;84:2014–2019.
   PubMed Web of Science ®Google Scholar
• Wolfe JT, Wang H, Perez-Reyes E, et al. Stimulation of recombinant Ca(v)3.2, T-type, Ca(2+) channel currents by CaMKIIgamma(C). J Physiol (Lond). 2002;538:343–355.
   Google Scholar
• Wen X, Li X, Liang H, et al. One cell model establishment to inhibit CaMKIIgamma mRNA expression in the dorsal root ganglion neuron by RNA interfere. Artif Cells Nanomed Biotechnol. 2017;45:1227–1233.
   PubMed Web of Science ®Google Scholar
• Li X, Peng C, Wang X, et al. One-cell model for inhibiting Cav3.3 mRNA expression by RNA interference. Biotechnol Biotechnol Equip. 2017;31:349–355.
   Web of Science ®Google Scholar
• Wen X, Xu S, Liu H, et al. Construction and identification of the pshRNA-CACNA1G-SH-SY5Ycells targeted to silence Cav3.1 mRNA expression. Biomed Rep. 2013; 1:669–673.
   PubMedGoogle Scholar
• Wen XJ, Li XH, Li H, et al. CaMK II γ down regulation protects dorsal root ganglion neurons from ropivacaine hydrochloride neurotoxicity. Sci Rep. 2017;7:5262.
   PubMed Web of Science ®Google Scholar